Drug intelligence / Profile preview

Odonton-Echtroplex

Development stage: Unknown
Lead developer: Weber & Weber
Modality: Small Molecules
Administration: Oral

Overview

Odonton-Echtroplex is a homeopathic complex preparation developed by Weber & Weber Biologische Arzneimittel for the treatment of inflammatory and degenerative conditions of the dental and oral systems. It is primarily indicated for gingivitis, periodontitis, and general inflammation of the oral mucosa. The formulation combines several homeopathic active ingredients, including *Arnica montana*, *Calcium fluoratum*, *Hekla lava*, *Silicea*, and *Symphytum officinale*, which are traditionally used to alleviate pain, reduce swelling, and support the regeneration of connective and bone tissues in the jaw. As a natural medicine, it aims to stimulate the body's self-regulatory processes to resolve inflammation and stabilize dental health.

Brand names: Odonton-Echtroplex
Other names: Odonton

Beyond the preview

Go deeper on Odonton-Echtroplex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Odonton-Echtroplex.

Explore the full profile